Contents
The Main Pharmaceutical Inspector (GIF) withdrew from the market in Poland a series of popular medicine for hypertension. A qualitative defect was detected in the preparation.
Bisoratio ASA – drug for hypertension withdrawn from the market
GIF announced the recall of one batch of Bisoratio ASA due to a quality defect. “Out of specification results were obtained in the parameter related substances and sum of bisoprolol impurities,” reads the decision.
Discontinued drug is Bisoratio ASA
- 5 mg + 75 mg
- hard capsules,
- 30 capsules,
- would 10819,
- expiration date: 08.2023.
The decision is immediately enforceable.
Bisoratio ASA – what is this drug?
Bisoratio ASA is a prescription drug. It contains acetylsalicylic acid and bisoprolol. It is used in the treatment of hypertension and in the treatment of ischemic heart disease.
The GIF decision only applies to one product series.
This may interest you:
- It could be a symptom of heart disease or high blood pressure
- Hypertension is a silent killer. These symptoms should be alarming
- These causes of hypertension are rarely mentioned
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.